Mezavitin Hataphar hard capsules treat cerebral circulation, memory loss (6 blisters x 10 tablets)

Dosage form Box of 6 blisters x 10 tablets
Specifications Rutin, vincamine

Ingredient

Composition information	Content
Rutin	40mg
Vincamine	20mg

Uses

indications

Mezavitin Hataphar is indicated in the following cases:

Supports the treatment of cerebral circulatory failure: Memory reduction, loss of concentration.

Supporting the endurance of capillaries. In addition, it also increases blood flow to places with ischemic.

rutin is an essential substance that creates cell collagen, protecting the walls, reducing capillary permeability.

Dynamic pharmacokinetics

The drug is quickly absorbed and reaches the maximum concentration in the blood after 2 hours.

The drug is excreted through the kidneys including 5 passing substances and Vincamin is not changed.

Before taking Mezavitin Hataphar hard capsules treat cerebral circulation, memory loss (6 blisters x 10 tablets)

How to use

should take the drug while eating.

Dosage

Adults: Take 1 tablet 1 tablet/day.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What do

do when using overdose? Focus on treating symptoms, supporting vomiting to avoid the absorption of the drug into the body.

What to do when you forget 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.

Side Effects

When using Mezavitin Hataphar, you may experience unwanted effects (ADR).

Very rare, ADR

Neurological: headache.

Systemic: rash. digestive: digestive disorders, diarrhea.

Sudden hypoglycemia.

Instructions on how to handle ADR

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

Mezavitin Hataphar is contraindicated in the following cases:

Patients with brain tissue proliferation with intracranial pressure.

Patients with a history of allergies to any ingredients of the drug.

Pregnant and lactating women.

Be cautious when used

In the sequelae of myocardial infarction and in the physical disorders of the heart rate, the dose must be increased slowly and during the treatment period, the electrocardiogram must be monitored. When in patients, the excitement changes due to hypotension, should only start treating after stabilizing the potassium.

Vincamine has no long -term hypotension and is not exempted for a specific treatment for high blood pressure.

Be cautious when used for pregnant and nursing women, infants.

The ability to drive and operate machinery

can be used.

Pregnancy

Contraindications to pregnant women.

breastfeeding period

Contraindicated women breastfeeding.

Drug interaction

Contraindications for coordination

Twisted drugs (Amiodarone, Bebridil, Bretylium, Disopyramide, Erythromycine intravenously, Quinidine, Sotalol, Sultopride): Increased risk of torsion.

Do not coordinate

Medications that cause hypotension: Amphotericine B (intravenous line), Gluco - Mineralocorticoid (systemic sugar), tetracosactide, hypokarin diuretics, stimulating laxative: The risk of torsion (hypotension is a favorable factor, as well as if the patient is suffering from long heart rate or QT).

For amphotericin b, diuretics, corticoide and tetracosactide: preventing blood potassium and adjustment if necessary; Follow QT. In case of torsion, no anti -arrhythmia (causing electrocardiogram).

For stimulating laxatives: instead of a group of non -stimulating laxatives.

Twisted drugs (Astemizole, Halofandrine, Pentamidine, Sparfloxacine, Terfenadine): Increased risk of torsion. If it is necessary to coordinate, it is recommended to strengthen clinical and electrocardiography.

Storage

Store in a dry place, temperatures below 30 ° C.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.